Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
New Hope for ALS Patients in Philly | Philadelphia News
In a groundbreaking ALS trial in Philadelphia, scientists are testing a new immune-focused therapy called Coya three-oh-two, designed to slow nerve damage by targeting harmful inflammation. For patients like Gregory Petry, whose life has dramatically shifted since his diagnosis, this research offers hope — even if he’s not eligible, he remains hopeful and resilient. Researchers at Temple Health urgently seek more participants for this potential breakthrough, with details available on the Coya Therapeutics website. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.